BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 21069685)

  • 1. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
    Paul M; Yahav D; Bivas A; Fraser A; Leibovici L
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
    Paul M; Yahav D; Fraser A; Leibovici L
    J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
    Tan X; Li Y; Xi J; Guo S; Su H; Chen X; Liang X
    Medicine (Baltimore); 2021 Dec; 100(50):e27266. PubMed ID: 34918626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
    Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
    PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
    Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
    Beyar-Katz O; Dickstein Y; Borok S; Vidal L; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003914. PubMed ID: 28577308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
    Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
    Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.
    Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
    Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
    Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
    Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.